| Publication No: | IN202411049745 [India] | Application No: | IN202411049745 |
| Title: | Isatin triazole conjugate analogues as anti-inflammatory agent and process for preparation thereof | ||
| Publication Date: | 02-01-2026 | File Date: | 28-06-2024 |
| Inventor(s): | Jonnala Kotesh Kumar; Kalavagunta Venkata Naga Satya Srinivas; Sarada Devi Tetali; A Niranjana Kumar; Smruti Ranjan Das | ||
| IPC Classification: | A61P29/00, C07D249/10, A61L27/38, C07D403/14, A61P31/04 | ||
| Abstract: | The present invention relates to Isatin-Triazole hybrid analogues as the anti-inflammatory effectiveness and process for preparation thereof. More particularly, the present invention relates to Isatin hybrid molecules with substituted 1,2,3-triazoles by click chemistry at room temperature in high yield. Further, The Isatin-Triazole hybrid analogues and evaluated in THP-1 cells induced with LPS. Notably, Isatin-1,2,3-triazole analogues demonstrated non-toxicity towards human monocytic THP-1 cells across three tested concentrations (150, 300 and 600 µg/ml), and it significantly reduced the expression of pro-inflammatory markers TNF-a, IL-6, and MCP-1 by multiple folds. | ||